샘플 요청 목록

 카트 문의
시장보고서
상품코드
1880730

세계의 분자진단 시장

Molecular Diagnostics
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 880 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 분자진단 시장은 2030년까지 270억 달러에 이를 전망

2024년에 160억 달러로 추정되는 세계의 분자진단 시장은 2024-2030년의 분석 기간에 CAGR 9.2%로 성장하여 2030년까지 270억 달러에 이를 것으로 예측되고 있습니다. 본 보고서에서 분석 대상이 된 부문 중 하나인 시약 및 키트 시장은 CAGR 9.7%로 성장하여 분석 기간 종료시에는 160억 달러에 이를 것으로 예측됩니다. 기기 부문의 성장률은 분석 기간에 CAGR 8.2%로 추정되고 있습니다.

미국 시장은 68억 달러로 추정되는 한편, 중국은 10.5%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다

미국의 분자진단 시장은 2024년에 68억 달러로 추정되고 있습니다. 세계 2위 경제대국인 중국은 2024-2030년의 분석 기간에 10.5%의 연평균 복합 성장률(CAGR)로 성장을 지속하여, 2030년까지 16억 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역 시장으로서는 일본과 캐나다를 들 수 있으며, 각각 분석 기간 중에 8.6%, 7.9%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 유럽에서는 독일이 약 8.4%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.

세계의 분자진단 시장 - 주요 시장 동향과 성장요인 개요

분자진단이란 무엇이며, 왜 중요한가?

분자진단은 분자생물학을 의료 검사에 적용하여 유전체(개인의 유전정보) 및 프로테옴(세포가 유전자를 단백질로 발현하는 메커니즘) 내의 생물학적 마커를 분석하는 일련의 기술입니다. 유전체 기술과 프로테옴 기술의 발전으로 이 분야는 크게 발전하여 질병의 검출, 진단 및 관리 방법에 혁명을 일으켰습니다. 분자진단은 질병의 유무에 관계없이 DNA나 RNA의 특정 염기서열을 검출하는 검사를 포함합니다. 감염성 질환 진단, 환자의 질병 발병 위험 파악, 암 조기 발견을 위한 DNA 마커 식별, 보다 맞춤화된 치료를 가능하게 하는 유전자 변이 검출 등에 널리 활용되고 있습니다. 이 진단법은 병원체나 돌연변이를 신속하게 식별하고 대응할 수 있다는 점에서 특히 높은 평가를 받고 있으며, 기존 방법보다 더 빠른 개입을 가능하게 하는 잠재력을 가지고 있습니다.

기술 발전은 분자진단을 어떻게 변화시키고 있는가?

분자진단의 기술 환경은 유전자 염기서열 분석, 하이스루풋 조사 방법 등의 분야에서 비약적인 발전에 힘입어 빠르게 진화하고 있습니다. 차세대 염기서열 분석(NGS) 기술은 수백만 개의 DNA 분자를 동시에 빠르게 염기서열 분석할 수 있어 유전자 분석 비용을 크게 절감하고 속도를 향상시킬 수 있습니다. 이 능력은 환자 개개인의 유전자 프로파일에 맞게 치료법을 조정할 수 있는 개인 맞춤형 의료 개발에 매우 중요합니다. 또한, 데이터 분석 도구와 바이오인포매틱스의 발전으로 방대한 양의 유전 데이터를 해석하고, 원시 데이터에서 실용적인 의료 지식으로 전환하는 데 도움을 주고 있습니다. 디지털 PCR 및 CRISPR 기반 진단 기술과 같은 혁신은 분자 검사의 정확성과 효율성을 높이고, 저농도 바이오마커 검출을 가능하게 하며, 높은 정확도를 제공합니다.

의료 분야에서의 주요 응용과 의의는?

분자진단은 암 검진부터 감염 및 만성질환 관리까지 의료의 다양한 분야에서 매우 중요한 역할을 하고 있습니다. 종양학에서 분자 검사는 특정 바이오마커를 식별하고 표적 치료의 적용을 위한 지침을 제공합니다. 감염병 분야에서는 병원체와 그 내성 프로파일을 신속하게 식별할 수 있는 능력을 제공하여 효과적인 치료와 대응에 필수적입니다. 또한, 분자진단은 약리유전체학의 발전에 필수적이며, 유전정보를 이용하여 환자의 약물반응을 예측함으로써 안전성과 유효성 향상에 기여하고 있습니다. 질병의 진행과 치료 반응을 실시간으로 모니터링하는 능력 또한 분자진단이 필수적인 분야로 부상하고 있으며, 의사가 질병을 보다 효과적으로 관리할 수 있는 새로운 도구를 제공합니다.

분자진단 시장의 성장을 이끄는 요인은?

분자진단 시장의 성장은 기술 발전, 감염성 질환 및 암 증가, 개인 맞춤형 의료에 대한 수요 증가, 소비자의 건강 인식 향상 등 여러 요인에 의해 촉진되고 있습니다. 하이스루풋 시퀀싱 기술의 통합으로 유전자 검사의 능력과 경제성을 획기적으로 향상시켜 보다 광범위한 계층이 이용할 수 있게 되었습니다. 이러한 접근성은 질병을 조기에 발견하고 개인에게 최적화된 치료법을 제공하는 데 있어 매우 중요하며, 개인 맞춤형 의료의 핵심입니다. 또한, 전 세계적으로 건강에 대한 인식이 높아지고 예방 의료 대책이 강화되면서 이러한 진단법에 대한 수요가 더욱 증가하고 있습니다. 정부와 의료기관도 분자진단이 건강 상태 개선에 기여하는 가치를 인식하기 시작했고, 이 기술에 대한 투자가 증가하고 있습니다. 또한, 보다 고도화된 데이터 분석 도구의 개발이 진행됨에 따라 유전자 데이터에서 보다 상세한 인사이트를 추출할 수 있게 되어 시장을 더욱 촉진하고 있습니다. 이러한 요소들이 결합되어 분자진단 분야의 지속적인 성장과 지속적인 혁신을 보장합니다.

부문:

컴포넌트(시약 및 키트, 기기, 소프트웨어 및 서비스), 기술(PCR, In-Situ Hybridization, 등온 증폭, 시퀀싱, 칩 및 마이크로어레이, 기타 기술), 용도(감염증, 종양학 검사, 유전자 검사, 기타 용도)

조사 대상 기업 예

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Asuragen, Inc.
  • Analytik Jena AG
  • A. Menarini Diagnostics Srl
  • Abaxis, Inc.
  • Agena Bioscience, Inc.
  • Advanced Cell Diagnostics, Inc.
  • AutoGenomics, Inc.
  • Akonni Biosystems, Inc.
  • Berg LLC
  • Agendia, Inc.
  • BioAgilytix Labs

AI 통합

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석을 혁신하고 있습니다.

Market Glass, Inc.는 LLM이나 산업 특화형 SLM을 쿼리하는 일반적인 방식이 아닌, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색엔진 조사, 그리고 방대한 양의 기업, 제품/서비스, 시장 데이터가 포함됩니다.

관세 영향 계수

Market Glass, Inc.가 본사 소재지, 생산기지, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하는 가운데, 이번 보고서에서는 지리적 시장에 대한 관세의 영향을 반영하였습니다. 이러한 복잡하고 다면적인 시장 현실은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 경쟁사들에게 다양한 영향을 미칠 것입니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.12.09

Global Molecular Diagnostics Market to Reach US$27.0 Billion by 2030

The global market for Molecular Diagnostics estimated at US$16.0 Billion in the year 2024, is expected to reach US$27.0 Billion by 2030, growing at a CAGR of 9.2% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$16.0 Billion by the end of the analysis period. Growth in the Instruments segment is estimated at 8.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.8 Billion While China is Forecast to Grow at 10.5% CAGR

The Molecular Diagnostics market in the U.S. is estimated at US$6.8 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 10.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.6% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Global Molecular Diagnostics Market - Key Trends & Drivers Summarized

What Is Molecular Diagnostics and Why Does It Matter?

Molecular diagnostics is a collection of techniques used to analyze biological markers in the genome and proteome-the individual's genetic code and how their cells express their genes as proteins-by applying molecular biology to medical testing. The field has grown significantly with advancements in genomic and proteomic technology, which have revolutionized how diseases are detected, diagnosed, and managed. Molecular diagnostics involves tests that can detect specific sequences in DNA or RNA that may or may not be associated with disease. Tests are often utilized to diagnose infectious diseases, understand a patient’s predisposition to a disease, identify DNA markers for the early detection of cancer, or detect genetic mutations that can drive more personalized treatments. This form of diagnostics is particularly renowned for its ability to rapidly identify and respond to pathogens and mutations, offering the potential for earlier intervention than traditional methods.

How Are Technological Advancements Shaping Molecular Diagnostics?

The technological landscape of molecular diagnostics is rapidly evolving, driven by leaps in areas such as gene sequencing and high-throughput methodologies. Next-generation sequencing (NGS) technologies allow for the simultaneous and rapid sequencing of millions of DNA molecules, greatly reducing the cost and increasing the speed of genetic analysis. This capability is crucial for the development of personalized medicine, where treatments can be tailored to the genetic profiles of individual patients. Additionally, improvements in data analysis tools and bioinformatics support the interpretation of vast amounts of genetic data, turning raw data into actionable medical insights. Digital PCR and CRISPR-based diagnostics are other innovations enhancing the precision and efficiency of molecular tests, allowing for the detection of low-abundance biomarkers and providing high levels of accuracy.

What Are the Key Applications and Implications in Healthcare?

Molecular diagnostics plays a pivotal role in several areas of healthcare, influencing everything from cancer screening to the management of infectious diseases and chronic conditions. In oncology, molecular tests help identify specific biomarkers that guide the use of targeted therapies. For infectious diseases, these diagnostics provide the ability to quickly identify pathogens and their resistance profiles, which is essential for effective treatment and control measures. Furthermore, molecular diagnostics is integral to the advancements in pharmacogenomics, where genetic information is used to predict patient responses to drugs, thereby improving safety and efficacy. The ability to monitor disease progression and response to treatment in real time is another area where molecular diagnostics is becoming indispensable, offering new tools for doctors to manage diseases more effectively.

What Drives the Growth of the Molecular Diagnostics Market?

The growth in the molecular diagnostics market is driven by several factors, including technological advancements, increasing prevalence of infectious diseases and cancer, rising demand for personalized medicine, and greater health awareness among consumers. The integration of high-throughput sequencing technologies has dramatically increased the capability and affordability of genetic testing, making it accessible to a broader population. This accessibility is crucial for the early detection of diseases and for tailoring specific therapies to individuals, which is at the heart of personalized medicine. Additionally, the global rise in health consciousness and preventive healthcare measures has heightened demand for these diagnostics. Governments and healthcare institutions are also recognizing the value of molecular diagnostics in improving health outcomes, leading to greater investment in this technology. Moreover, the ongoing development of more sophisticated data analysis tools has enabled the extraction of more detailed insights from genetic data, further propelling the market forward. These factors collectively ensure sustained growth and continual innovation within the field of molecular diagnostics.

SCOPE OF STUDY:

The report analyzes the Molecular Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Reagents & Kits, Instruments, Software & Service); Technology (PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays, Other Technologies); Application (Infectious Disease, Oncology Testing, Genetic Testing, Other Applications)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 84 Featured) -

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Beckman Coulter, Inc.
  • Asuragen, Inc.
  • Analytik Jena AG
  • A. Menarini Diagnostics Srl
  • Abaxis, Inc.
  • Agena Bioscience, Inc.
  • Advanced Cell Diagnostics, Inc.
  • AutoGenomics, Inc.
  • Akonni Biosystems, Inc.
  • Berg LLC
  • Agendia, Inc.
  • BioAgilytix Labs

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Molecular Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Molecular Diagnostics: An Introduction
    • Types of Molecular Diagnostics Tests
    • Market Outlook
    • Major Growth Drivers
    • Developing Countries Offer Strong Growth Prospects
    • PCR Technology Leads the MDx Market
    • Infectious Diseases: The Largest Application Market
    • Reagents and Kits Dominate the Molecular Diagnostics Market
    • Competition
    • Pharmaceutical Firms Carve their Niche in Molecular Diagnostic Market
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Technological Innovations Set to Drive Market Growth
    • New Product Developments
    • Digitalization Trends Benefit Growth
    • Growing Role of Molecular Diagnostics in Personalized Medicine
    • Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025
    • Companion Diagnostics Drive Personalized Medicine
    • Biomarkers as Companion Diagnostics
    • Oncology-Based Molecular Diagnostics Lead Growth
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • New Applications Hold Promising Potential
    • Next-Generation Sequencing (NGS) Technologies Keep Up the Momentum
    • Rising Emphasis on Lab Automation to Augur Well for Market Growth
    • World Laboratory Automation Market in US$ Billion for Years 2018, 2020, 2022, 2024 & 2026
    • Nanotechnology for Molecular Diagnostics
    • Growing Popularity of Chemo-Sensitivity Testing of CTCs
    • Genetic Disease Testing Offers Bright Prospects
    • Genetic Testing to Aid in Personalized Medicine
    • Pharmacogenomics Development Augurs Growth of Genetic Testing Market
    • Non-Invasive Prenatal Diagnostics - The Way Ahead
    • Nucleic Acid Amplification Methods for Detection of Antimicrobial Resistance
    • Growing Incidence of Infectious Diseases Spurs Opportunities
    • Infectious Diseases Remain Major Cause of Death in Under Developed Regions: Breakdown of Leading Causes of Death in Sub-Saharan Africa (in %)
    • PCR Plays a Vital Role in the Diagnosis of Infectious Diseases
    • Rising Incidence of Hospital Acquired Infections Propels Market Growth
    • Greater Number of Tests for HIV and Sexually Transmitted Diseases Amplify Growth
    • Rapid HIV Tests: A New Age Diagnostic Weapon against the Killer Disease
    • Home HIV Testing Emerges as a Lucrative Option
    • Molecular Tests Gaining Prominence in GC/Chlamydia Testing Market
    • Molecular Diagnostics Opens New Avenues in Viral Hepatitis Testing
    • Hepatitis B prevalence Worldwide by Region
    • HPV Testing: A Fast Growing Segment in the Molecular Diagnostic Testing Market
    • Cervical Cancer: Rising Incidence & Mortality Enhances Need for Testing
    • Molecular based Tests Ingrain Roots in Blood Donor Screening Segment
    • Rise in Healthcare Expenditure to Drive Growth
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2024
    • Aging Population Drives Molecular Diagnostics Market
    • Elderly Healthcare Expenditure as a % of GDP
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 3: World 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Reagents & Kits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 6: World 16-Year Perspective for Reagents & Kits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 9: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Software & Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Software & Service by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 12: World 16-Year Perspective for Software & Service by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for PCR by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 15: World 16-Year Perspective for PCR by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for In-Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for In-Situ Hybridization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 18: World 16-Year Perspective for In-Situ Hybridization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Isothermal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Isothermal Amplification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 21: World 16-Year Perspective for Isothermal Amplification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 24: World 16-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Chips & Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Chips & Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 27: World 16-Year Perspective for Chips & Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 30: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Infectious Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 33: World 16-Year Perspective for Infectious Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Oncology Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 36: World 16-Year Perspective for Oncology Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Genetic Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 39: World 16-Year Perspective for Genetic Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 42: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 43: World Molecular Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • Market Analytics
    • Market Overview
    • Infectious Disease Testing Contributes to High Growth
    • Ageing Demographics: Major Driving Factor
    • US Elderly Population: Expected Growth Rates Over the Years 2005-2025
    • Increasing Incidence of Chronic Diseases Drives Focus onto Molecular Diagnostics
    • Rising Incidence of Cancer: A Major Growth Driver
    • Molecular Diagnostics Tests Gain Share in STD Testing Domain
    • HPV Testing Market: A Review
    • Prevalence of HPV in the US by Age
    • US Personalized Medicine Market to Offer Significant Opportunities
    • Companion Diagnostics Market in the US
    • Burgeoning Potential for Genetic Testing
    • Paradigm Shift amongst Consumers Spurs DTC Genetic Testing Market
    • TABLE 44: USA Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • JAPAN
    • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • Market Overview
    • Brief Note on COVID-19 Testing in Japan
    • Demographics Drive Market Growth
    • Breakdown of Population by Age Group in Japan: 2010, 2020, and 2025
    • Market Analytics
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • CHINA
    • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • Market Overview
    • COVID-19 Testing: An Overview
    • HPV Testing in China
    • Market Analytics
    • TABLE 71: China Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: China 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: China 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: China 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • EUROPE
    • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • Market Overview
    • Aging Population: A Prime Growth Driver
    • Automated Systems Gain Preeminence
    • Oncology-based Molecular Diagnostics Holds Immense Potential
    • Number of New Cancer Cases in Europe: 2012, 2018, and 2025
    • HPV Testing in Europe: An Overview
    • Market Analytics
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Molecular Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • FRANCE
    • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: France 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: France 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: France 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • GERMANY
    • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Spain 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Spain 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Spain 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Russia 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Russia 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Russia 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • Market Overview
    • Healthcare Spending in Asia-Pacific: On the Rise
    • Market Analytics
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Molecular Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Australia 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Australia 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Australia 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • INDIA
    • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • Market Overview
    • Laboratories Pick up on Automation
    • HPV Testing Market: An Overview
    • HPV in India: Breakdown of Type-Distribution and HPV Prevalence
    • Market Analytics
    • TABLE 176: India Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: India 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: India 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 182: India Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: India 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: South Korea 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: South Korea 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: South Korea 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Molecular Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Latin America 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Latin America 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Latin America 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 214: Latin America 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 217: Argentina 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 220: Argentina 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 223: Argentina 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 226: Brazil 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 229: Brazil 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 232: Brazil 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 235: Mexico 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 238: Mexico 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 241: Mexico 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Molecular Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 253: Middle East 16-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 256: Middle East 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 259: Middle East 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 262: Middle East 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 265: Iran 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 268: Iran 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 271: Iran 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 274: Israel 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 277: Israel 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 280: Israel 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 292: UAE 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 295: UAE 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 298: UAE 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030
  • AFRICA
    • Molecular Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Molecular Diagnostics by Component - Reagents & Kits, Instruments and Software & Service Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 310: Africa 16-Year Perspective for Molecular Diagnostics by Component - Percentage Breakdown of Value Sales for Reagents & Kits, Instruments and Software & Service for the Years 2014, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Molecular Diagnostics by Technology - PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 313: Africa 16-Year Perspective for Molecular Diagnostics by Technology - Percentage Breakdown of Value Sales for PCR, In-Situ Hybridization, Isothermal Amplification, Sequencing, Chips & Microarrays and Other Technologies for the Years 2014, 2025 & 2030
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Molecular Diagnostics by Application - Infectious Disease, Oncology Testing, Genetic Testing and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 316: Africa 16-Year Perspective for Molecular Diagnostics by Application - Percentage Breakdown of Value Sales for Infectious Disease, Oncology Testing, Genetic Testing and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제